1 min read
Zymeworks Sets $200 Million Limit for Second 2026 Buyback Program
The company expects about $140 million in repurchases through 2028 and plans to begin buying shares before year-end.

Zymeworks Inc. (Nasdaq: ZYME) said its board approved a second share repurchase program for 2026, authorizing up to $200 million in purchases and setting a limit on the company’s planned buybacks.
The company expects to repurchase about $140 million in shares through 2028. It plans to begin purchases before the end of 2026.
The $200 million authorization is the program’s maximum, while $140 million is the company’s expected purchase amount. Zymeworks disclosed the board’s approval Monday, Nov. 16.